Kahn Swick & Foti Initiates Investigation into Owlet, Inc.
Former Attorney General, Charles C. Foti, Jr., a partner at Kahn Swick & Foti, LLC, has announced the start of an investigation concerning Owlet, Inc. Owlet, formerly known as Sandbridge Acquisition Corporation (NYSE: OWLT), is under scrutiny following significant regulatory challenges related to its Smart Sock product.
Background of the Investigation
On October 4, 2021, Owlet revealed it had received a warning letter from the U.S. Food and Drug Administration (FDA). This letter indicated that the marketing practices regarding the Owlet Smart Sock may classify it as a medical device, necessitating premarket clearance or approval from the FDA. The letter specifically instructed the company to discontinue the product's distribution, particularly when it comes to measuring blood oxygen saturation and heart rates.
Impact of the FDA Warning
In light of the FDA's concerns, the company and certain executives became embroiled in a securities class action lawsuit. This legal action accused them of failing to disclose critical information during this turbulent time, which allegedly violated federal securities laws. The judicial authority overseeing the case has recently denied Owlet's motion to dismiss, thereby allowing the case to progress, adding pressure on the company.
Focus of the Investigation
Kahn Swick & Foti's investigation is directed at determining whether Owlet's officers or directors have breached their fiduciary duties to shareholders. There may also be potential violations of state or federal laws, which KSF aims to uncover. This thorough examination is essential for protecting the rights of the company's investors.
How Investors Can Assist
Individuals who hold Owlet shares for an extended period or possess relevant information that could aid in the investigation are encouraged to step forward. Kahn Swick & Foti invites potential whistleblowers or investors to contact them at no obligation. They can reach out via a toll-free number to discuss their legal rights and share any insight they may have regarding the company's actions.
About Kahn Swick & Foti, LLC
Kahn Swick & Foti, LLC, recognized as one of the leading boutique securities litigation law firms in the United States, represents a diverse portfolio of clients. These include institutional investors, hedge funds, and retail investors. The firm aims to secure recoveries for clients facing investment losses due to corporate fraud or malfeasance in publicly traded companies. With offices situated in multiple states, including New York and California, KSF boasts a dedicated team committed to advocating for investor rights.
Connecting with KSF
For more information about Kahn Swick & Foti and their ongoing investigations or legal services, individuals can visit their official website. They are dedicated to facilitating communication and providing transparency about their processes and findings.
Frequently Asked Questions
What triggered the investigation into Owlet, Inc.?
The investigation was initiated in response to a warning letter from the FDA regarding the marketing practices of Owlet's Smart Sock product.
What are the potential implications for Owlet?
Owlet may face legal consequences if found to have breached fiduciary duties or violated securities laws during the FDA warning period.
How can investors participate in the investigation?
Investors can share information or discuss their legal rights by contacting Kahn Swick & Foti at their toll-free number.
What services does Kahn Swick & Foti offer?
KSF specializes in securities litigation, representing clients seeking recoveries from corporate misconduct or fraud.
Where can I find more information about KSF?
More information can be found on Kahn Swick & Foti's official website, detailing their services and current cases.
